Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience
Allergy and Asthma Proceedings · 2023
DOI: 10.2500/aap.2023.44.220103 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Allergy and Asthma Proceedings, 2023. Verfasst von Gulfem Elif Celik und 13 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Immunology and Allergy, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Nasal Polyps, Asthma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Aspirin treatment after desensitization (ATAD) is effective in preventing nasal polyps recurrence as well as respiratory symptoms in patients with nonsteroidal anti-inflammatory drug (NSAID)‐exacerbated respiratory diseases (N-ERD). However, there is no consensus on effective daily maintenance doses in ATAD. Therefore, we aimed to compare the effects of two different maintenance doses of aspirin on clinical outcomes for 1‐3 years of ATAD.
Methods
This was a retrospective, multicenter study that involved four tertiary centers. The maintenance doses of daily aspirin were 300 mg in one center and 600 mg in the remaining three. The data of patients who were on ATAD for 1‐3 years were included. Study outcomes (nasal surgeries, sinusitis, asthma attacks, hospitalization, oral corticosteroid use, and medication uses) were assessed in a standardized way and recorded from case files.
Results
The study initially included 125 subjects, 38 and 87 were receiving 300 and 600 mg daily aspirin for ATAD, respectively. Number of nasal polyp surgeries decreased after 1 -3 years compared with before ATAD in both groups (group 1, baseline: 0.44 ± 0.07 versus first year: 0.08 ± 0.05; p < 0.001 and baseline: 0.44 ± 0.07 versus 3rd year: 0.01 ± 0.01; p < 0.001; and group 2, baseline 0.42 ± 0.03 versus first year: 0.02 ± 0.02; p < 0.001 and baseline: 0.42 ± 0.03 versus 3rd year: 0.07 ± 0.03; p < 0.001).
Conclusion
Given the comparable effects of 300 mg and 600 mg aspirin daily as maintenance treatment of ATAD on both asthma and sinonasal outcomes in N-ERD, our results suggest using 300 mg of aspirin daily in ATAD owing to its better safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Immunology and Allergy, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
- Division of Immunology and Allergy, Department of Chest Diseases, Hacettepe University School of Medicine, Ankara, Turkey.
- Department of Immunology and Allergy, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.
- Division of Immunology and Allergy, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey.
- Division of Immunology and Allergy, Department of Internal Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
- Department of Ear Nose and Throat, Hacettepe University School of Medicine, Ankara, Turkey.
Zitieren
APA
Celik, G. E., Karakaya, G., Erkekol, F. O., Dursun, A. B., Gelincik, A., Aydin, O., Damadoglu, E., Yucel, T., Yorulmaz, I., Dursun, E., Buyukatalay, Z. C., Sozener, Z. C., Buyukozturk, S., & Kalyoncu, A. F. (2023). Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience. Allergy and Asthma Proceedings. https://doi.org/10.2500/aap.2023.44.220103
Vancouver
Celik GE, Karakaya G, Erkekol FO, Dursun AB, Gelincik A, Aydin O, et al. Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience. Allergy and Asthma Proceedings. 2023. doi:10.2500/aap.2023.44.220103
BibTeX
@article{Celik2023,
author = {Celik, Gulfem Elif and Karakaya, Gul and Erkekol, Ferda Oner and Dursun, Adile Berna and Gelincik, Asli and Aydin, Omur and Damadoglu, Ebru and Yucel, Taskin and Yorulmaz, Irfan and Dursun, Engin and Buyukatalay, Zahide Ciler and Sozener, Zeynep Celebi and Buyukozturk, Suna and Kalyoncu, Ali Fuat},
title = {Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience},
journal = {Allergy and Asthma Proceedings},
year = {2023},
doi = {10.2500/aap.2023.44.220103}
}
EUVIMED